Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Toshinobu Tokumoto*†‡, Mika Tokumoto*†, Ryo Horiguchi§¶, Katsutoshi Ishikawa*, and Yoshitaka Nagahama†§
*Department of Biology and Geosciences, Faculty of Science, Shizuoka University, Shizuoka 422-8529, Japan; †CREST Research Project, Japan Science and
Technology Corporation, Kawaguchi 332-0012, Japan; §Laboratory of Reproductive Biology, National Institute for Basic Biology, Okazaki 444-8585, Japan;
and ¶Department of Molecular Biomechanics, Graduate University for Advanced Studies, Okazaki 444-8585, Japan
Communicated by Howard A. Bern, University of California, Berkeley, CA, January 6, 2004 (received for review August 6, 2003)
Treatment 0.1 M 1 M 2 M
EtOH 0
17,20-DHP 83.3 ⫾ 6.3 98.3 ⫾ 2.9 98.3 ⫾ 2.9
DES 0 18.3 ⫾ 6.3 85.0 ⫾ 8.7
-Estradiol 0 0 0
17␣-Estradiol 0 0 0
Ethynylestradiol 0 0 0
Resveratorol 0 0 0.8 ⫾ 1.4
o,p⬘-DDT 0 0 0
p,p⬘-DDT 0 0 0
Butyl benzyl phthalate 0 0 0
Di(2-ethylhexyl)phthalate 0 0 0
Bisphenol A 0 0 0
p-Nonylphenol 0 0 0
4-Octylphenol 0 0 0
Pentachlorophenol 0 0 0
PHYSIOLOGY
were visualized by using the ECL detection kit (Amersham
Biosciences).
inducing GVBD was investigated by using goldfish oocytes
cDNA Cloning and Production of Recombinant Proteins. Recently, a
(Table 1). Of the 13 agents tested, only DES was effective in
strong candidate for an MIH membrane receptor has been inducing GVBD. As in the previous report (8), two other
identified and characterized in spotted seatrout (19). We cloned estrogens (-estradiol and ethynylestradiol) and 17␣-estradiol
cDNA for this membrane progestin receptor ␣ (mPR␣) from did not induce GVBD at the concentration tested. Eight kinds
goldfish. Details of cDNA cloning of a homologue of mPR␣ will of EEDCs (DDTs, phthalates, and phenols) did not induce
be described elsewhere. GST-tagged recombinant protein of a GVBD at the doses tested.
fragment of 78 N-terminal amino acids of goldfish mPR␣ was
produced. 35S-Labeled mPR␣ was produced by using a TNT DES Induces Natural Oocyte Maturation. Fig. 1A shows the mor-
T7-coupled Reticulocyte Lysate System (Promega) according to phology of oocytes after 6 h of EtOH, 17,20-DHP, and DES
the manufacturers instructions. treatment. Germinal vesicles were seen near the center of
oocytes after EtOH treatment, whereas they disappeared after
Antibody Production. Full-length goldfish cyclin B was produced the 17,20-DHP and DES treatments. Also, 17,20-DHP- and
in Escherichia coli BL21 (DE3) and 78 N-terminal amino DES-treated oocytes became transparent and changed color to
acids of goldfish mPR␣ was produced in E. coli XL1Blue. a bright yellow. DES also induced the translation of cyclin B
These were purified by SDS兾PAGE, and subsequently ob- protein (Fig. 1B), a well characterized intracellular molecular
tained from the gel by electroelution (20). Polyclonal antibod-
event that results in an elevation of the kinase activity of
ies specific for cyclin B and the receptor protein were raised
against purified recombinant proteins according to a proce- maturation-promoting factor. These results show that the
dure described by using guinea pigs (21). Antisera that rec- DES-induced maturation was identical with the physiological
ognize the 48-kDa band of cyclin B and the 40-kDa band of maturation of oocytes as judged by several criteria.
mPR␣ were obtained.
Possible Target of DES in Inducing GVBD. To address the target of
Results DES in the signal transduction pathway to induce GVBD, as
Relative Potency of Various Substances in Inducing Fish Oocyte a first step, the time-course changes of GVBD induced by DES
Maturation. The relative effectiveness of MIH and 13 other were compared with those of GVBD induced by 17,20-DHP.
agents, including EEDCs and several steroid hormones, in The time course of oocyte maturation induced by DES was the
EtOH 0
The percentage of GVBD was calculated by determining the percentage of oocytes that had undergone GVBD in a group composed
of ⬎20 oocytes cultured in parallel for 3 h. Each value in the mean (⫾ SD) of three separate experiments with ovaries of three separate
females. ** and * indicate statistically significant differences between the percentage of GVBD induced by the same concentration of
DES and DES analogues at the P ⬍ 0.01 and P ⬍ 0.05 levels, respectively.
PHYSIOLOGY
treatment of oocytes with a nonsteroidal substance, DES, alone for their potential interaction with the MIH receptor. These
induces maturation. The morphology and an intracellular mo- compounds might also have the ability to induce oocyte
lecular event induced by DES and 17,20-DHP were indistin- maturation in fish.
guishable and suggest that, at least qualitatively, DES and To understand whether DES acts by means of the MIH
17,20-DHP induced the same type of maturation. However, a receptor specific for 17,20-DHP, we used indirect strategy by
difference occurred between the relative potency of DES to raising an antibody against goldfish mPR␣. Both 17,20-DHP-
induce oocyte maturation and that of 17,20-DHP. Other and DES-induced oocyte maturation was inhibited by this anti-
EEDCs did not induce GVBD at the doses examined in this body. These findings, together with data from time-course
study, although we cannot rule out the possibility that these studies and synergistic effects, suggest that DES may interact
agents might have effects at higher doses. with the MIH receptor. Further evidence to support these
In general, the potency and biological properties of a mechanisms of DES action is required.
compound can be predicted from its structure. It is possible, It is well known that DES is a ligand for estrogen receptors (22,
23). However, interaction between DES and other physiological
therefore, to dissect the contribution of a particular structural
receptors has been reported recently (24–26). Orphan nuclear
modification of a compound that binds to the 17,20-DHP
receptors are members of the nuclear receptor family that lack
receptor to the biological response of a target. To study the
identified ligands (27). Recent studies have identified several
structural requirement for the MIH action of DES, the relative natural and synthetic ligands for orphan nuclear receptors, which
potency of DES analogs to induce GVBD was compared. All led to new hormone-response systems implicated in the control
of the compounds except DM-DES induced a dose-related of various aspects of development and adult physiology (28, 29).
stimulation of oocyte maturation similar to that induced by Among orphan nuclear receptors, the estrogen-related receptors
17,20-DHP, although potencies were significantly different have been reported to be inhibited in their binding with coac-
(17,20-DHP ⬎ DES, HEX ⬎ DIES, and DP-DES ⬎ DMS). tivator protein by DES. In trophoblast stem cells, DES promotes
This analytical approach to the structure–activity relationships coactivator release from estrogen-related receptor  and inhibits
of compounds revealed that ethyl groups and hydroxyls of DES its transcriptional activity (25). By using fluorescence resonance
contribute to the interaction between DES and the MIH energy transfer assay, it has also been shown that DES binds to
receptor. Other compounds, such as 4-hydroxytamoxifen and estrogen-related receptor ␥ (26). These findings suggest a path-
bisphenol, have structural features similar to DES necessary way for DES action as a ligand for receptors besides estrogen
receptors. Likewise, this study shows that DES may interact with We thank Dr. J. A. Katzenellenbogen for the gift of DMS. This work was
the MIH receptor. supported by the CREST Research Project of Japan Science and
Many EEDCs, including DES, may mimic the action of the sex Technology Corporation (to Y.N.) and by grants-in-aid for Scientific
Research on Priority Areas from the Ministry of Education, Culture,
hormone estradiol and are therefore referred to as xenoestro- Sports, Science and Technology of Japan. Part of this study was
gens. We show here the possibility that they mimic other steroids. performed as the National Institute for Basic Biology Cooperative
Our findings emphasize the need for studies to examine more Research Program (00-121 and 01-112 to T.T). M.T. is a Research Fellow
widely the various nonestrogenic effects of endocrine disrupters. of the Japan Science and Technology Corporation.
1. Ishikawa, K., Hanaoka, Y., Kondo, Y. & Imai, K. (1977) Mol. Cell. Endocrinol. 16. Westerfield, M. (1995) in The Zebrafish Book: A Guide for the Laboratory Use
9, 91–100. of Zebrafish (Danio rerio) (Univ. of Oregon Press, Eugene).
2. Godeau, J. F., Schorderet-Slatkine, S., Hubert, P. & Baulieu, E. E. (1978) Proc. 17. Lessman, C. A. & Kavumpurath, S. (1984) Gamete Res. 10, 21–29.
Natl. Acad. Sci. USA 75, 2353–2357. 18. Laemmli, U. K. (1970) Nature 227, 680–685.
3. Yoshikuni, M., Shibata, N. & Nagahama, Y. (1993) Fish Physiol. Biochem. 11, 15–24. 19. Zhu, Y., Rice, C. D., Pang, Y., Pace, M. & Thomas, P. (2003) Proc. Natl. Acad.
4. Masui, Y. & Clarke, H. J. (1979) Int. Rev. Cytol. 57, 185–282. Sci. USA 100, 2231–2236.
5. Nagahama, Y. & Adachi, S. (1985) Dev. Biol. 109, 428–435. 20. Hirai, T., Yamashita, M., Yoshikuni, M., Lou, Y. H. & Nagahama, Y. (1992)
6. Patino, R. & Thomas, P. (1990) Gen. Comp. Endocrinol. 78, 474–478. Mol. Reprod. Dev. 33, 131–140.
7. Yamashita, M., Kajiura, H., Tanaka, T., Onoe, S. & Nagahama, Y. (1995) Dev. 21. Tokumoto, T., Tokumoto, M., Seto, K., Horiguchi, R., Nagahama, Y., Yamada,
Biol. 168, 62–75. S., Ishikawa, K. & Lohka, M. J. (1999) Exp. Cell Res. 247, 313–319.
8. Nagahama, Y., Hirose, K., Young, G., Adachi, S., Suzuki, K. & Tamaoki, B.
22. Katzenellenbogen, B. S., Iwamoto, H. S., Heiman, D. F., Lan, N. C. &
(1983) Gen. Comp. Endocrinol. 51, 15–23.
Katzenellenbogen, J. A. (1978) Mol. Cell. Endocrinol. 10, 103–113.
9. Thomas, P. (1999) in Endcrine Disruptors: Effects on Male and Female
23. Prins, G. S., Birch, L., Couse, J. F., Choi, I., Katzenellenbogen, B. & Korach,
Reproductive Systems, ed. Naz. R. K. (CRC, Boca Raton, FL), pp. 3–38.
10. Bern, H. A. (1992) in Chemically Induced Alterations in Sexual and Functional K. S. (2001) Cancer Res. 61, 6089–6097.
Development: The Wildlife兾Human Connection, eds. Collborn. T. & Clement. C. 24. Lu, D., Kiriyama, Y., Lee, K. Y. & Giguere, V. (2001) Cancer Res. 61, 6755–6761.
(Princeton Scientific Publishing, Princeton, NJ.), pp. 9–15. 25. Tremblay, G. B., Kunath, T., Bergeron, D., Lapointe, L., Champigny, C., Bader,
11. Young, G., Kagawa, H. & Nagahama, Y. (1982) J. Exp. Zool. 224, 265–275. J. A., Rossant, J. & Giguere, V. (2001) Genes Dev. 15, 833–838.
12. Trant, J. M. & Thomas, P. (1988) Gen. Comp. Endocrinol. 71, 307–317. 26. Coward, P., Lee, D., Hull, M. V. & Lehmann, J. M. (2001) Proc. Natl. Acad.
13. Pandey, S. & Hoar, W. S. (1972) Can. J. Zool. 50, 1679–1680. Sci. USA 98, 8880–8884.
14. Jalabert, B. (1975) C. R. Hebd. Seances Acad. Sci. D 281, 811–814. 27. Giguere, V. (1999) Endocr. Rev. 20, 689–725.
15. Sundararaj, B. I., Goswami, S. V. & Lamba, V. (1979) J. Steroid Biochem. 11, 28. Blumberg, B. & Evans, R. M. (1998) Genes Dev. 12, 3149–3155.
701–707. 29. Kliewer, S. A., Lehmann, J. M. & Willson, T. M. (1999) Science 284, 757–760.